SGS scientific, regulatory and clinical experts support you in designing a smart strategy to bring your drug from the non-clinical to clinical phase of development. As an industry leader in early phase drug development, we navigate your products through the regulatory and development obstacles, by integrating operational considerations early on.
Our Development Consultancy team has the following key offerings:
- Development strategy: non-clinical and clinical development plans, Target Product Profile (TPP), Set-up of Scientific Advisory Boards
- Agency Meetings (EMA, FDA…) to validate and support your strategy
- Clinical trial design
- Development of CMC, non-clinical and clinical documentation
- Preparation and submission of CTA / INDs
Partnering with SGS means having access to our:
- Worldwide recognized expertise in early phase development
- Dedicated and fully integrated consultancy team
- Modeling and simulation group
- Client centered approach, with special focus on small and spin-off companies
|
